Sign Up! | Tags | Domains | Statistics | Options | Advanced Search
|
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
bizjournals.com » San Jose Business News - Local San Jose News | The Silicon Valley / San Jose Business Journal - Feb 25, 2010
Geron Corp. on Thursday reported a fourth quarter loss of $18.4 million, or 20 cents a share, widened from $17.6 million, or 22 cents as hare in the same period last year. (GERN)
streetinsider.com » StreetInsider.com News Articles - Feb 24, 2010
The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session: Before The Market Opens Economics: 8:30am EST Initial Claims - Street sees 460K Continuing Claims - Street sees …
Also tagged: golf, clr, gps, pcs, omg, sd, nem, ctl, kss, vg, fire, acu, bee, hnz, ovti, adc, ysi, dt, swn, swy, gxp, eme, linta, fto, trw, rev, nihd, esv, pxp, anss, pei, es, rep, wtr, spw, cm, vit, nvtl, nrf, lamr, lkqx, sjw, wr, cec, cde, erie, wti, cnl, zeus, flml, erf, mhk, kbr, nxtm, iclr, orcc, lava, fwlt, eres, sqm, cogt, dlr, flr, nmrx, gls, ica, sbac, pkd, vlcm, ggb, tdsc, navg, emci, cgv, gna, fpo, kdn, mcri, psb, awi, ipxl, aciw, rst, spwra, ltxc, relv
schaeffersresearch.com » SchaeffersResearch.com Trading Floor Blog - Feb 16, 2010
Despite an utter lack of news hitting the wires, put activity has ramped up on Geron Corporation (GERN) today...(Read More)
seekingalpha.com » Healthcare Sector and Stocks Analysis from Seeking Alpha - Feb 1, 2010
The Burrill Report submits: Geron (GERN) is teaming up with the University of California to investigate the therapeutic potential of its human embryonic stem cell-based product, GRNOPC1, for Alzheimer’s disease. While …
Also tagged: the burrill report
bizjournals.com » San Jose Business News - Local San Jose News | The Silicon Valley / San Jose Business Journal - Jan 26, 2010
Geron Corp. said Tuesday it entered into a collaboration jointly funded by Geron and a University of California Discovery Research and Training Grant to investigate the therapeutic potential of its human embryonic stem …
bloggingstocks.com » BloggingStocks - Jan 15, 2010
Filed under: Newsletters, Stocks to Buy "Geron (GERN) is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and …
Also tagged: stem cell research, steven halpern, thestockadvisors com, bi research, biotech stocks, biotechnology stocks, stem cell stocks, tom bishop, geron
seekingalpha.com » Biotech Sector and Stocks Analysis from Seeking Alpha - Jan 12, 2010
Joe Feshbach submits: Joseph L. Feshbach has over 25 years of professional investment experience, using both long and short equity strategies. Additionally he has been Chairman and CEO of a publicly traded healthcare …
Also tagged: isrg, osir, dndn, cytx, hgsi, mdvn, joe feshbach
istockanalyst.com » Medical: iStockAnalyst.com Feed - Jan 6, 2010
The stock market indices ground it out today with two distinct performances from the S&P 500 and Nasdaq 100. While the NDX was in a down-channel all day, the SPX was in a slight up-channel all day, and they …
Also tagged: osi, nlst, osis, tasr, cga, bexp, seed, tstc, uso, spx, caas, useg, hgsi, hitk, incy, ndx, ndy
streetinsider.com » StreetInsider.com News Articles - Dec 10, 2009
Visit StreetInsider.com at http://www.streetinsider.com/Insiders+Blog/Stem+Cell+Stocks+Tick+Higher+After+NIH+Blood+Stem-Cell+Transplant+Regimen+Reverses+Sickle+Cell+Disease+in+Adults+/5174470.html for the full story.
schaeffersresearch.com » SchaeffersResearch.com Trading Floor Blog - Dec 3, 2009
As explained in our education section, short interest is a useful sentiment indicator that measures the level of investor pessimism toward a stock...(Read More)